Trends in Fidelis lead survival: Transition from an exponential to linear pattern of lead failure over time

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 5, 2012, Pages 906-912

  Cheung, Jim W ^a   Tobin Hess, Aviva ^b   Patel, Apoor ^b   Slotwiner, David J ^b   Goldner, Bruce G ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Failure rate; Implantable cardioverter defibrillator; Lead advisory; Lead failure

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIAC PATIENT; DEFIBRILLATION; DEVICE SAFETY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PACEMAKER FAILURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; CHI SQUARE DISTRIBUTION; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HEART ARRHYTHMIA; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; TIME; UNITED STATES;

AGED; ARRHYTHMIAS, CARDIAC; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEW YORK; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84872008738     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.972000     Document Type: Article

References (18)

1. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. Minneapolis, MD: Medtronic Inc; October 15, 2007.
2. Sprint Fidelis model 6949 lead performance. http://www.medtronic.com/ product-advisories/physician/sprint-fidelis/6949-LEAD-PERFORMANCE. Accessed January 27, 2012.
3. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4:892-896.
4. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605-610.
5. Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010;105:95-99.
6. Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead. J Cardiovasc Electrophysiol. 2010;21:671-677.
7. Ha AC, Vezi BZ, Keren A, Alanazi H, Gollob MH, Green MS, Lemery R, Nery PB, Posan E, Birnie DH. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead. Pacing Clin Electrophysiol. 2010;33:437-443.
8. Ricci RP, Pignalberi C, Magris B, Aquilani S, Altamura V, Morichelli L, Porfili A, Quarta L, Saputo F, Santini M. Can we predict and prevent adverse events related to high-voltage implantable cardioverter defibrillator lead failure? J Interv Card Electrophysiol. 2012;33:113-121.
9. Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, Morrison TB, Hayes DL. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management. Circulation. 2011;123:358-363.
10. Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A, Coutu B, Kus T, Mangat I, Ayala-Paredes F, Nery P, Wells G, Krahn AD. Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation. 2012;125: 1217-1225.
11. Farwell D, Green MS, Lemery R, Gollob MH, Birnie DH. Accelerating risk of Fidelis lead fracture. Heart Rhythm. 2008;5:1375-1379.
12. Tzogias L, Bellavia D, Sharma S, Donohue TJ, Schoenfeld MH. Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study. J Interv Card Electrophysiol. 2012;34:37-44.
13. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
14. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA; National Cardiovascular Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078-1084.
15. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV; Investigators of the Ontario ICD Database. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774-782.
16. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation. 2010;121:2384-2387.
17. Maytin M, Love CJ, Fischer A, Carrillo RG, Garisto JD, Bongiorni MG, Segreti L, John RM, Michaud GF, Albert CM, Epstein LM. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J Am Coll Cardiol. 2010;56:646-650.
18. Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Reiser C. Clinical study of the laser sheath for lead extraction: the total experience in the United States. Pacing Clin Electrophysiol. 2002;25:804-808.